Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de Madrid  >  FAES Farma SA    FAE   ES0134950F36

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Madrid
07/17/2017 07/18/2017 07/19/2017 07/20/2017 07/21/2017 Date
2.79(c) 2.775(c) 2.73(c) 2.7(c) 2.71 Last
272 230 308 666 357 305 619 053 237 015 Volume
+1.27% -0.54% -1.62% -1.10% +0.37% Change
More quotes
Financials (€)
Sales 2017 246 M
EBIT 2017 51,1 M
Net income 2017 41,0 M
Finance 2017 61,8 M
Yield 2017 1,67%
Sales 2018 265 M
EBIT 2018 57,8 M
Net income 2018 44,5 M
Finance 2018 84,7 M
Yield 2018 2,69%
P/E ratio 2017 16,83
P/E ratio 2018 15,06
EV / Sales2017 2,63x
EV / Sales2018 2,35x
Capitalization 709 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
11/14Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
06/16 FAES FARMA SA : ex-dividend day for final dividend
2016 FAES FARMA SA : Cash amount paid with the scrip issue offered as an alternative ..
2016 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA SA : Cash amount paid with the scrip issue offered as an alternative ..
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
2015 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
2015 FAES FARMA SA : BONUS ISSUE: 1 new share for 50 existing shares
2015 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA SA : Cash amount paid with the scrip issue offered as an alternative ..
More news
Sector news : Pharmaceuticals - NEC
07/21 FTSE, sheltered from euro strength, has best week since May
07/21DJGLAXOSMITHKLINE : FDA Approves Injectable Form Of Glaxo's Benlysta
07/21 GlaxoSmithKline's new CEO prepares to trim drug pipeline
07/21 AstraZeneca CEO reassures staff, aims to be at September cancer meet
07/20 Abbott profit forecast gets a lift from St. Jude integration
More sector news : Pharmaceuticals - NEC
Latest Tweets
2015#Spain: Faes Farma : #Market Analysts predicted Oct 2015 sales growth & p.. 
2015#Frankfurt #stocks: Faes Farma : #Merger #Acquisition Analysts say: soft Aug .. 
2015Faes Farma desembarca en China mediante una 'joint venture' con Eddingpharm  
2015BRIEF-Faes Farma reaches license agreement for its product in USA  
2015#Frankfurt #stocks: Faes Farma : #Market Analysts conclude meagre sales profi.. 
More tweets
Qtime:14
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Technical analysis trends FAES FARMA SA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 3,35 €
Spread / Average Target 23%
EPS Revisions
Managers
NameTitle
Gonzalo López Casanueva Co-Managing Director
Francisco Quintanilla Guerra Co-Managing Director
Mariano Ucar Angulo Chairman
Valentín Ruiz Unamunzaga Deputy MD & Director-Corporate Finance
Isidro Hermo Blanco Manager-Pharmaceutical Technology
Sector and Competitors
1st jan.Capitalization (M$)
FAES FARMA SA-19.35%826
JOHNSON & JOHNSON17.45%364 503
ROCHE HOLDING LTD.5.46%221 492
NOVARTIS9.72%220 936
PFIZER3.08%199 378
MERCK AND COMPANY6.39%171 303